Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury

Histone deacetylases (HDACs) inhibitors are promising therapeutic agents against proteinuric kidney diseases, here, we investigated the effect of MC1568, a selective inhibitor of HDAC class IIa, on the development and progression of nephrotic syndrome in a murine model induced by Adriamycin (ADR). I...

Full description

Bibliographic Details
Main Authors: Xu He, Tao Sun, Pei Zhang, Zhengkun Xia, Chunlin Gao, Hongqi Ren, Daxi Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.848938/full
_version_ 1818061648743628800
author Xu He
Tao Sun
Pei Zhang
Zhengkun Xia
Chunlin Gao
Hongqi Ren
Daxi Ji
Daxi Ji
author_facet Xu He
Tao Sun
Pei Zhang
Zhengkun Xia
Chunlin Gao
Hongqi Ren
Daxi Ji
Daxi Ji
author_sort Xu He
collection DOAJ
description Histone deacetylases (HDACs) inhibitors are promising therapeutic agents against proteinuric kidney diseases, here, we investigated the effect of MC1568, a selective inhibitor of HDAC class IIa, on the development and progression of nephrotic syndrome in a murine model induced by Adriamycin (ADR). In kidney tissues of FSGS patients, all four members of HDAC IIa were significantly upregulated in podocytes. In ADR-treated cultured human podocyte, expression of HDAC IIa were induced, meanwhile inhibition of HDAC IIa with MC1568 restored cytoskeleton structure and suppressed expression of desmin and α-SMA. In mice, administration of MC1568 at 14 days after ADR ameliorated proteinuria and podocyte injury, also decreased expression of Fibronectin and α-SMA. Mechanistically, MC1568 inhibited ADR induced β-catenin activation in vitro and in vivo. Together, these finding demonstrate that HDAC IIa inhibition ameliorates podocyte injury and proteinuria, which provide a possibility that MC1568 may be used in nephrotic syndrome.
first_indexed 2024-12-10T13:51:40Z
format Article
id doaj.art-1211d2c63eef45568b0a9f851c6cd17d
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-10T13:51:40Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-1211d2c63eef45568b0a9f851c6cd17d2022-12-22T01:46:07ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-04-01910.3389/fmed.2022.848938848938Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte InjuryXu He0Tao Sun1Pei Zhang2Zhengkun Xia3Chunlin Gao4Hongqi Ren5Daxi Ji6Daxi Ji7Department of Pediatrics, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, ChinaDepartment of Pediatrics, Jinling Hospital, Nanjing, ChinaDepartment of Pediatrics, Jinling Hospital, Nanjing, ChinaDepartment of Pediatrics, Jinling Hospital, Nanjing, ChinaDepartment of Pediatrics, Jinling Hospital, Nanjing, ChinaDepartment of Nephrology, Affiliated Huaihai Hospital of Xuzhou Medical University, Xuzhou, ChinaDepartment of Pediatrics, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, ChinaDepartment of Nephrology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, ChinaHistone deacetylases (HDACs) inhibitors are promising therapeutic agents against proteinuric kidney diseases, here, we investigated the effect of MC1568, a selective inhibitor of HDAC class IIa, on the development and progression of nephrotic syndrome in a murine model induced by Adriamycin (ADR). In kidney tissues of FSGS patients, all four members of HDAC IIa were significantly upregulated in podocytes. In ADR-treated cultured human podocyte, expression of HDAC IIa were induced, meanwhile inhibition of HDAC IIa with MC1568 restored cytoskeleton structure and suppressed expression of desmin and α-SMA. In mice, administration of MC1568 at 14 days after ADR ameliorated proteinuria and podocyte injury, also decreased expression of Fibronectin and α-SMA. Mechanistically, MC1568 inhibited ADR induced β-catenin activation in vitro and in vivo. Together, these finding demonstrate that HDAC IIa inhibition ameliorates podocyte injury and proteinuria, which provide a possibility that MC1568 may be used in nephrotic syndrome.https://www.frontiersin.org/articles/10.3389/fmed.2022.848938/fullpodocyte injuryproteinuriaHDACβ-cateninnephrotic syndrome
spellingShingle Xu He
Tao Sun
Pei Zhang
Zhengkun Xia
Chunlin Gao
Hongqi Ren
Daxi Ji
Daxi Ji
Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
Frontiers in Medicine
podocyte injury
proteinuria
HDAC
β-catenin
nephrotic syndrome
title Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
title_full Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
title_fullStr Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
title_full_unstemmed Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
title_short Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
title_sort selective inhibition of histone deacetylase class iia with mc1568 ameliorates podocyte injury
topic podocyte injury
proteinuria
HDAC
β-catenin
nephrotic syndrome
url https://www.frontiersin.org/articles/10.3389/fmed.2022.848938/full
work_keys_str_mv AT xuhe selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury
AT taosun selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury
AT peizhang selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury
AT zhengkunxia selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury
AT chunlingao selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury
AT hongqiren selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury
AT daxiji selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury
AT daxiji selectiveinhibitionofhistonedeacetylaseclassiiawithmc1568amelioratespodocyteinjury